Cancer

Response

UNSW Medicine’s cancer researchers are internationally recognised clinicians, researchers and educators. Our expertise spans the basic sciences, clinical trials, implementation research, public health and health services research.

Many of our researchers are also clinicians who work in Local Health Districts in Southeast Sydney and Southwest Sydney. Our research is conducted in renowned centres and institutes including the Ingham Institute for Applied Medical Research, the Lowy Cancer Research Centre, the Children’s Cancer Institute, the Garvan Institute of Medical Research and the Centre for Big Data Research in Health. These connections give us access to highly sophisticated equipment including whole genome sequencing, high-throughput chemical small molecule screening and advanced fluorescence microscopy, as well as clinical trials capability and access to statistical and big data support.

We also collaborate widely and have partnerships with consumers, government and non-government organisations, charities and industry to ensure that our work is clinically relevant and rapidly implemented.

Our research comprises cancer basic sciences, including genomic work, biobanking, pharmacology, stromal biology, tumour biology, cancer stem cell biology, histone modification and epigenetics, as well as drug development, clinical trials, epidemiology, pharmaco-epidemiology and health services research.

The Children’s Cancer Institute is undertaking a substantial personalised medicine program and we are running a number of projects through Prince of Wales Hospital examining early identification, health professional education, wider family engagement and psycho-social research in cancer. The Kids Cancer Centre at Sydney Children’s Hospital conducts studies of the psychosocial and behavioural aspects of paediatric cancer affecting children and their families, and nutrition for children receiving cancer treatment.

Our research into cancer survivorship includes the identification and treatment of long term morbidity related to treatment, as well as the role of exercise as therapy, interaction with general practice and patient-led models of care.